Formulating Solutions for the Pharmaceutical and Biotechnology Industries
Every data point is a small piece in a greater whole, and that little piece is an integral part of how your drug is understood and how it is developed. All of these pieces fit together and compliment each other and it is our responsibility to see this, understand the bigger picture, and tell your story to others. We are here to build your development story piece by piece.
At Pharmosaic Consulting, we are dedicated to improving patient outcomes by upholding high ethical standards, contributing to social responsibility, and through patient-centric drug development approaches. Our mission is to lead advancements in pharmaceutical development with innovative solutions, scientific rigor, and leveraging our deep scientific expertise. We pride ourselves on adaptability and flexibility, and using the appropriate tools and approaches tailored to each program’s unique goals. Through collaboration, shared responsibility, and transparency, we achieve shared goals and make a positive impact on your program and our communities.
Providing Expert Biopharmaceutical Development Consulting Solutions
- Specializing in API selection, preformulation, and formulation development for liquid and semisolid dosage forms
- Expertise in drug product development for topical, mucosal and injectable dosage forms for systemic and local delivery
- Skilled in incorporating small molecules and biologics into commercializable dosage forms
- Implementing cutting-edge technologies in drug development
Patient Centric
Dedicated to improving patient outcomes while adhering to high ethical standards and contributing to the community
Innovation
Leading advancements with cutting-edge technologies and rigorous scientific methodologies, driven by deep expertise
Adaptability
Employing the appropriate tools and approaches tailored to unique development goals, ensuring versatile and flexible solutions
Collaboration
Fostering strong partnerships and shared responsibility with transparent and collaborative practices
